Concepedia
Statistics
Publications
1
Citations
38
H-Index
Active since
2022
Affiliations
China Pharmaceutical University(Current)
Zhengyang Fei is an author at China Pharmaceutical University.
Publications per year
2022–2022
Cost-effectiveness analysis of sintilimab + chemotherapy versus camrelizumab + chemotherapy for the treatment of first-line locally advanced or metastatic nonsquamous NSCLC in China
Mingjun Rui, Zhengyang Fei, Yingcheng Wang et al. · Journal of Medical Economics · 2022 · 38 citations · Full text
1–1 of 1